✨ Medicines Classification
NEW ZEALAND GAZETTE, No. 16 — 25 FEBRUARY 2016
Cholic acid
CJC-1295
Daclatasvir
Defibrotide
Elbasvir
Felbamate
Flunarizine
Grazoprevir
Growth Hormone Releasing Peptide-6
Growth Hormone Releasing Hormones
Growth Hormone Releasing Peptides
Idebenone
Influenza vaccine; except when administered to a person 13 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health
Lesinurad
Levomilnacipran
Methylhexanamine (1,3-dimethylamylamine (DMAA)); except when present as an unmodified, naturally occurring medicine
Milnacipran
Naloxegol
Netupitant
Nitazoxanide
Nivolumab
Pentostatin
Ponatinib
Picibanil
Pralmorelin
Ranitidine; except when specified elsewhere in this schedule; except in medicines containing 300 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than seven days’ supply
Rufinamide
Sargramostim
Stiripentol
Steptozocin
Sunifiram
Tizanidine
Trientine
Ulipristal
Schedule 2
Restricted Medicines
Cyclizine; for oral use other than in medicines used for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than six dosage units; for oral use in medicines used for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units
Schedule 3
Pharmacy-only Medicines
Ranitidine; in medicines for the symptomatic relief of heartburn, dyspepsia and hyperacidity or to be used on the recommendation of a registered medical practitioner when sold in the manufacturer’s original pack containing
Next Page →
✨ LLM interpretation of page content
🏥
Classification of Medicines
(continued from previous page)
🏥 Health & Social WelfareMedicines Act, Prescription Medicines, Restricted Medicines, Pharmacy-only Medicines
NZ Gazette 2016, No 16